Overall, our work supports the notion that while inhibition of FGFR4 signaling exerts acute and direct anti-proliferative effects on HCC cells, the surviving sub-population may be clonally selected for a resilient, stem cell-like phenotype. The gene discussed is FGFR4; the disease is hepatocellular carcinoma.